Point-of-care Tests for Bacterial Vaginosis and Candidosis

NCT ID: NCT04287504

Last Updated: 2021-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-14

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vaginal infection in early pregnancy is associated with an increased risk of spontaneous preterm delivery and late miscarriage. Most studies presume that vaginal infections are responsible for up to 40% of preterm birth. Although the causative microorganisms of vaginal infections are manifold, the three pathogens most commonly associated with vaginal infections are Gardnerella vaginalis, Candida albicans and Trichomonas vaginalis. The aim of this prospective study is the validation of the point-of-care tests OSOM BVBLUE for bacterial vaginosis and SavvyCheck Vaginal Yeast Test for candidosis in comparison to Gram stain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the present study, it should be examined whether the OSOM BVBLUE for bacterial vaginosis and the SavvyCheck Vaginal Yeast Test for vaginal candidosis are superior, equal/comparable or inferior to diagnosis on Gram stained smears. The point-of-care-tests are potential tools for the adequate diagnosis of bacterial vaginosis and vaginal candidosis in early pregnancy, since the prevention of these infections, as well as the infection screening per se, have the potential to prevent preterm birth and reduce the rate of late abortion. Point-of-care-tests are easy to perform, relatively cheap, and widely available. Routine implementation of the tests would be an effective contribution to the reduction of preterm labor and late-onset mortality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection, Bacterial Infection, Fungal Preterm Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Yeast, control

Women negative for vulvovaginal candidosis on Gram stain smear.

SavvyCheck Vaginal Yeast Test

Intervention Type DIAGNOSTIC_TEST

Point-of-care test for the detection of vaginal candidosis

Yeast, study group

Women positive for vulvovaginal candidosis on Gram stain smear.

SavvyCheck Vaginal Yeast Test

Intervention Type DIAGNOSTIC_TEST

Point-of-care test for the detection of vaginal candidosis

Bacterial vaginosis, control

Women negative for bacterial vaginosis on Gram stain smear.

OSOM BVBLUE Test

Intervention Type DIAGNOSTIC_TEST

Point-of-care test for the detection of bacterial vaginosis

Bacterial vaginosis, study group

Women positive for bacterial vaginosis on Gram stain smear.

OSOM BVBLUE Test

Intervention Type DIAGNOSTIC_TEST

Point-of-care test for the detection of bacterial vaginosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SavvyCheck Vaginal Yeast Test

Point-of-care test for the detection of vaginal candidosis

Intervention Type DIAGNOSTIC_TEST

OSOM BVBLUE Test

Point-of-care test for the detection of bacterial vaginosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Legal age (Participants must be 18 years or over)
* Singleton pregnancy
* No recent therapy with antibiotics within the last two weeks
* No application of the following in the previous 72 hours before testing: vaginal ointments/crèmes, douches, spermicides, vaginal lubricants or feminine sprays

Exclusion Criteria

* Age below 18 years
* Multiple pregnancy
* Recent treatment with antibiotics
* Application of the following in the previous 72 hours: vaginal ointments/crèmes, douches, spermicides, vaginal lubricants or feminine sprays
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alex Farr, MD PhD

Assistant Professor, Consultant Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Herbert Kiss, MD MBA

Role: STUDY_DIRECTOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna, Dept. of Obstetrics and Gynecology

Vienna, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philipp Foessleitner, MD BSc

Role: CONTACT

+43140400 ext. 28220

Alex Farr, MD PhD

Role: CONTACT

+43140400 ext. 28220

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Philipp Foessleitner, MD BSc

Role: primary

+43140400 ext. 28220

Alex Farr, MD PhD

Role: backup

+43140400 ext. 28220

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2115-2019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Point-of-care Tests for Vaginal Discharge in Nepal
NCT05977491 ACTIVE_NOT_RECRUITING NA